NCT06698003 2026-03-05A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1Memorial Sloan Kettering Cancer CenterPhase 2 Recruiting134 enrolled
NCT04689659 2025-05-18Multi-centers, Open-Label, Phase 2 Study to Evaluate the Efficacy and Safety of Donor-Derived CD7 CAR T Cells in Subjects With Relapsed or Refractory T-cell Leukemia/LymphomaBeijing Boren HospitalPhase 2 Completed55 enrolled